BPI Boston
Continuous bioprocessing next logical step after single-use adoption, Pall
The strong adoption of single-use technology is enabling industry to transition towards continuous bioprocessing systems, says Pall Corporation.
Archives for October 5, 2016
Dispatches from CPhI Worldwide
Single-use tech will impact the 'extremely consolidated' bio-CMO space, expert
Lonza and Boehringer-Ingelheim dominate the consolidated biologics CMO space but disposable technologies and improved yields are beginning to change this, says PharmSource’s Jim Miller.
Lonza constructing dedicated suite to make Clovis breakthrough mAb
Lonza will construct a dedicated suite to produce commercial supply of rucaparib API on behalf of Clovis Oncology.